BioMedNewsBreaks - Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial

Stock Information for Soligenix Inc.

Loading

Please wait while we load your information from QuoteMedia.